共 107 条
[1]
Slamon DJ(2001)Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783-792
[2]
Leyland-Jones B(2014)HER2 in breast cancer: a review and update Adv Anat Pathol 21 100-107
[3]
Shak S(2021)Targeting HER2 expression in cancer: new drugs and new indications Bosn J Basic Med Sci 21 1-4
[4]
Fuchs H(2015)HER2 expression status in diverse cancers: review of results from 37,992 patients Cancer Metastasis Rev 34 157-164
[5]
Paton V(2018)Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years Mod Pathol 31 607-615
[6]
Bajamonde A(2014)Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer Cancer 120 2657-2664
[7]
Krishnamurti U(2011)Immuno-imaging using nanobodies Curr Opin Biotechnol 22 877-881
[8]
Silverman JF(2021)HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging Eur J Nucl Med Mol Imaging 48 1371-1389
[9]
Vranic S(2000)Cubilin is an albumin binding protein important for renal tubular albumin reabsorption J Clin Invest 105 1353-1361
[10]
Beslija S(2005)Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide J Nucl Med 46 1696-1700